Market
BD uplifts FY26 revenue outlook based on steady portfolio performance
Becton Dickinson raised its FY26 revenue guidance, reversing a prior downward revision from Q1 that stemmed from the divestiture of its diagnostics business to Waters Corporation. The uplift reflects improved performance across BD's remaining portfolio.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network